Introduction {#sec1-1}
============

Breast cancer is ranked as number one cancer among women in India, and the age-standardized incidence rate was found to be 25.8/100,000 females.\[[@ref1][@ref2][@ref3][@ref4]\] However, the role of various risk factors leading to breast cancer is not adequately understood in our country setting. Based on the breast cancer risk factor profiling, countries have developed their own risk prediction tools or models and these risk assessment models are established and validated based on the known risk factors for breast cancer in white women. The Breast Cancer Risk Assessment Tool developed by the United States National Institute of Health for Cancer is based on inputs over medical history of breast cancer or precancerous conditions including age of individual, age at menarche, age at first childbirth, family history of breast cancer, biopsy findings, and ethnicity.\[[@ref5]\] The Gail Model has been modified to account for the history of atypia and race or ethnicity, but until now, it has included only nonmodifiable risk factors (age, reproductive history, biopsy history, etc.,) among white American women. Barlow in 2006 constructed separate risk models which are slightly more complex than the Gail Model and are based on breast density as an indicator or breast cancer risk.\[[@ref6][@ref7][@ref8][@ref9]\]

Some of these models and similar instruments have been tested on Asian population; however, ethnic and geographic differentials make them less predictive. The physical examination of the breast by paramedical workers has also been evaluated as an alternative screening tool. A regular self-breast examination is also helping the woman in detecting the onset of breast cancer. Detecting cancer, when it is in the very early stage, can improve the cure rate from breast cancer. For effective breast cancer prevention, the assessment of community risk is of critical importance so that a targeted intervention is possible, optimizing resource utilization and yielding best results. Risk communication combined with suitable and customized intervention is the key to a successful anticancer campaign. The current study aims at developing a questionnaire-based risk assessment score for breast cancer in the community.

Methodology {#sec1-2}
===========

A cross-sectional survey with multistage random number-based cluster sampling technique was used for validating the usefulness of the instrument. A study population considered for the interview was women of 18--64 years. The sample size was calculated as per the World Health Organization STEPS Manual for Noncommunicable Disease Risk Factors Survey. A target sample size was taken at 500. With a 10% nonresponse, the actual target was fixed at 550.\[[@ref10]\] The eligible participants were identified from each randomly selected panchayats and municipalities by the study investigator with the help of junior public health nurses at subcenter or primary health-care centers. The study was conducted with the objective of developing a risk-based assessment score on the grounds of the prevalence of known risk factors of breast cancer in the community.

The risk factors identified for the assessment of breast cancer risk factors in the community were as follows: (1) prevalence of ≥40 years, (2) percentage of participants married at 30 years and above, (3) percentage of participants with age at menarche below 13 years, (4) percentage of participants by age at first childbirth, (5) percentage of participants with age at menopause of 49 or above among all menopausal participants, (6) percentage of abortions among ever-married women, (7) average fat consumption/week in KCal, (8) percentage of body mass index 25 and above, (9) percentage of breast diseases (benign and malignant) cases, and (10) percentage of family history of breast cancer.

Each participant was explained the purpose of the study. Written consent was obtained from the study participants. The presented study proposal was approved by the Institutional Ethics Committee of the National Centre for Disease Control, New Delhi.

Data analysis {#sec2-1}
-------------

The values were obtained in different scales/units for each risk factor considered for the study. Age was measured in completed years, fat consumption in grams per week, etc., These quantitative values were converted into ordinal values for comparison. To facilitate a composite estimation of risk, these values were classified in 5-point modified Likert scale from minimum to maximum value.\[[@ref10]\]

Results were compiled, collated, and analyzed in rates and proportions. For comparing the proportions obtained in the current study with other studies StataV9, statistical software was used. Test of significance to measure internal validity of scoring by modified Likert scale was Cronbach\'s alpha (α). The equation used was as follows: α Cronbach\'s = (k/k-1) × {1-ΣS~i~ ^2^/S~Total~ ^2^}\[[@ref11][@ref12]\] where,

K = number of items in the scored questionnaireS~i~= standard deviation of scores for each itemS~Total~= standard deviation of total score of all the items.

Results {#sec1-3}
=======

The risk assessment score {#sec2-2}
-------------------------

A total of 564 participants in the age group of 18--64 years from 345 households were approached for the survey. The analysis of 558 participants was performed excluding six incomplete forms. The known risk factors for breast cancer included history of reproductive factors, nutritional intake, and anthropometry.

The prevalence of these known risk factors of breast cancer estimated was re-assorted for analysis of in the study community. These re-assorted data are categorized into range of values across the communities \[[Table 1](#T1){ref-type="table"}\].

###### 

Re-assorted prevalence of risk factors of breast cancer in the communities

  Range                            Age     Age at   Abortions   Average fat intake/week in KCal   BMI     Breast disease   Family history of Breast Cancer                  
  -------------------------------- ------- -------- ----------- --------------------------------- ------- ---------------- --------------------------------- ------- ------ -----
  Highest                          62      11.1     83.3        11.8                              87.5    26.7             2988                              40.4    10     8.8
  Median                           40.5    2.65     46.6        4.6                               66.7    18.6             2320                              14.3    3.35   2
  Lowest                           28.1    0        0           0                                 37.5    7.7              1840                              7.3     0      0
  Score key for the risk factors                                                                                                                                            
   1                               20-29   \<2      \<30        \<2                               \<40    \<10             \<2000                            \<15    \<2    \<2
   2                               30-39   2,3      30-39       2,3                               40-54   10-14            2000-2199                         15-19   2      2-3
   3                               40-49   4,5      40-49       4,5                               55-69   15-19            2200-2399                         20-24   3      4-5
   4                               50-59   6,7      50-59       6,7                               70-84   20-24            2400-2699                         25-29   4      6-7
   5                               60-69   ≥8       ≥60         ≥8                                ≥85     ≥25              ≥2700                             ≥30     ≥5     ≥8

BMI=Body mass index

On the basis of this range of values, a 5-point modified Likert scale has been prepared to capture lowest to highest value. The scale is given with a scoring key for each risk factor. With the Likert scale score for each item reflected, statistical test was applied to check validity and robustness of the scale. The composite scores obtained have been reproduced in [Table 2](#T2){ref-type="table"} which summarizes the scoring scale for assessment of breast cancer risk factors in the community.

###### 

Composite scores for the 12 study communities for calculating Cronbach's Alpha

  Risk factors                             Community (C)                                           
  ---------------------------------------- --------------- --- --- --- --- --- --- --- --- --- --- ---
  Percentage age ≥40                       2               3   2   3   5   3   2   3   2   3   2   1
  Percentage age at marriage ≥30           3               2   2   2   2   5   2   5   1   1   1   1
  Percentage age at menarche \<13          4               4   1   3   2   3   3   2   5   3   4   3
  Percentage age at first childbirth ≥30   3               4   1   3   5   4   2   5   1   2   1   4
  Percentage age at menopause ≥49          4               5   3   4   3   5   3   3   3   3   4   1
  Percentage abortions                     3               2   4   1   5   3   4   2   3   4   5   3
  Average fat intake in KCal               3               5   2   5   3   2   3   3   1   4   3   4
  Percentage BMI ≥25                       5               4   1   1   5   1   1   1   1   2   1   5
  Percentage breast diseases               4               3   1   1   5   1   4   2   2   5   5   3
  Percentage family history of BrCa        3               2   1   1   2   1   2   2   2   4   1   5

The test of significance used in this study is Cronbach\'s α or α Cronbach\'s. [Table 3](#T3){ref-type="table"} gives Cronbach\'s α value for breast cancer risk factor survey and its basis.

###### 

Cronbach's alpha for breast cancer risk factor survey

  Component                 Value             Computation
  ------------------------- ----------------- -------------
  K                         10                
  K-1                                         9
  (K/K-1)                                     1.111111
  Σ Si^2^                   18.01515          
  Σ S~total~^2^             30.51515          
  ΣSi^2^/ΣS~total~^2^                         0.590367
  1 - (ΣSi^2^/ΣStotal^2^)                     0.409633
  α~Cronbach's~             0.455147 or 46%   

Discussion {#sec1-4}
==========

According to the recent 2017 estimates of the Global Burden of Disease study, the prevalence of breast cancer globally is around 16,697,300 globally \[[Table 4](#T4){ref-type="table"}\].\[[@ref13]\] There are various behavioral, environmental, metabolic, and occupational risk factors that contribute to the growing burden (disability-adjusted life years) of breast cancer\[[@ref14][@ref15]\] as shown in [Table 5](#T5){ref-type="table"}. The prevalence of risk factors of breast cancer in the current study gives a cross-sectional picture of the community. The number of first-degree relatives diagnosed with breast cancer is one of the major risk factors which is also included in the Gail Model Breast Cancer Risk Assessment Tool,\[[@ref7][@ref16]\] and these findings were also validated from other studies.\[[@ref17][@ref18][@ref19]\] The scoring system used in Likert scale is based on the actual range of values on the ground and validates the relevance of known risk factors of breast cancer as observed in studies conducted abroad in Indian conditions. Internal validity of this tool is reflected in the Cronbach\'s α value of 45.5, which is moderately good.

###### 

Global burden, years lived with disability, and disability-adjusted life years of breast cancer

  Prevalence (thousands) 2017 counts   Incidence (thousands) 2017 counts   YLDs (thousands) 2017 counts   Percentage change in YLDs counts, 1990-2007   Percentage change in YLDs counts, 2007-2017   All age- DALYs (thousands) 2017   Percentage change in DALYs 2007-2017
  ------------------------------------ ----------------------------------- ------------------------------ --------------------------------------------- --------------------------------------------- --------------------------------- --------------------------------------
  16,697.3 (16178.9-17171·7)           1960.7 (1891.4-2023.2)              1307.9 (932.0-1769.3)          67.7% (60.6-72.7)\*                           33.8% (29.0-37.7)\*                           17400 (16900-18700)               24.6% (18.1-29.3)\*

\*Statistically significant increase. YLDs=Years lived with disability, DALYs=Disability-adjusted life years

###### 

Global estimation of various risk factors contributing to breast cancer

  Behavioral/environmental/occupational risk factor   2007 deaths (thousands)   2017 deaths (thousands)   Percentage change in deaths, 2007-2017   2007 DALYs         2017 DALYs         Percentage change in DALYs, 2007-2017
  --------------------------------------------------- ------------------------- ------------------------- ---------------------------------------- ------------------ ------------------ ---------------------------------------
  Tobacco smoking                                     16 (12-21)                17 (12-22)                5.2% (1.9-8.4)\*                         447 (317-582)      451 (320-593)      0.8% (−2.5-3.8)\*
  Second hand smoke                                   12 (3-21)                 15 (4-26)                 21.2% (14.3-26.9)\*                      404 (98-688)       478 (118-829)      18.5% (11.6-24.6)\*
  Alcohol use                                         54 (46-62)                59 (49-69)                9.7% (4.3-14.1)\*                        1560 (1320-1790)   1670 (1390-1940)   7.0% (2.0-11.3)\*
  Low physical activity                               7 (0-17)                  9 (0-21)                  25.9% (20.8-30.5)\*                      205 (4-470)        253 (5-575)        23.4% (17.7-28.5)\*
  High fasting plasma glucose                         33 (6-73)                 44 (9-99)                 35.2% (27.9-43.9)\*                      805 (153-1800)     1070 (205-2430)    33.5% (25.4-42.4)\*
  High body mass index                                26 (10-48)                40 (16-71)                54.8% (39.2-88.4)\*                      487 (125-983)      817 (267-1530)     67.7% (45.5-153.1)\*

\*Statistically significant increase. DALYs=Disability-adjusted life years

Inadequate knowledge of breast cancer risk factors and poor cancer screening practices for breast cancer among female patients makes it difficult to identify high-risk groups. These high-risk groups should be educated and requires careful follow-ups with good screening modalities. Furthermore, improved ways of follow-up using identification of various putative genes such as BRCA-1 and BRCA-2 can also be employed. Hence, the study of family history in a population helps in screening of breast cancer and predisposition to breast cancer.\[[@ref20]\] The Epidemiology and Genomics Research Program under the Division of Cancer Control and Population Sciences in National Cancer Institute discussed the breast cancer risk prediction models in detail. The available models are categorized to the Absolute Risk Prediction Models, Gene Carrier Status Risk Prediction Models, Risk Prediction Models of Women at High Risk, and Online Risk Assessment Tools and Calculators.

These statistical models estimate the probability of developing cancer over a defined period of time. This will help clinicians identify individuals at higher risk of specific cancers. This will further, encourage them in imparting routine screening and genetic counseling as best health-seeking behaviors among the potential patients leading to the reduction in the burden of the disease. These types of models also will be useful for designing future chemoprevention and screening intervention trials in individuals at high risk of specific cancers in the general population.\[[@ref21]\]

The most common model used to predict woman\'s risk of developing breast cancer is Gail Model and it is useful in targeting screening and prevention efforts. The multivariate risk model developed by Gail *et al*. is widely used for quantifying the risk of breast cancer within a specified time in women at various ages and with certain risk factors. A case--control study was conducted at Regional Cancer Center, Thiruvananthapuram, to determine the usefulness of Gail Model Breast Cancer Risk Assessment Tool in identifying women at high risk for breast cancer proved that Gail Model cannot be used to predict high-risk women in Kerala.\[[@ref22]\] Numerous mathematical models were also made using these risk factors to predict individual women\'s risk of developing breast cancer. There is a paucity of data regarding the risk factors in our society.

Conclusions {#sec1-5}
===========

The Cronbach\'s α value with the survey conducted with these items was 45.5 indicating good internal validity. The risk assessment tool was found suitable for use in the current study field situation. The current study design has the scope of being up scaled for use in a larger study that may lead to a more internally valid reflection of risk in the population. The risk assessment tool has collated most of the risk factors of breast cancer that are capable of being measured at community level. Based on the experience of this study, a risk assessment tool with scoring system has also been evolved. This may be used for community surveys for risk assessment, and based on the Cronbach\'s α value of \<40, 40--69, and ≥70, the validity of such assessment results may be taken as low, moderate, or high.

The known risk factors of breast cancer validated by international studies were used for assessment of risk factor prevalence of breast cancer in this study. This has given a fair idea of prevalence of these risk factors in India. This list of 10 risk factors for the assessment of community risk for breast cancer can be used in other surveys of similar kind. It is recommended that this composite comprehensive risk assessment tool for risk assessment of breast cancer in the community as a composite instrument with the 10 items with given scores. A larger study using the instrument shall lead to refinement and piloting of an important community-based risk assessment tool.
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